Patents by Inventor Philip Johnson

Philip Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230258005
    Abstract: A screeding machine for screeding uncured concrete includes a base unit, a support mechanism disposed at an end portion of the base unit, and a screed head assembly supported at the support mechanism. The screed head assembly includes (i) a grade establishing member and (ii) a vibrating member. The support mechanism includes a lateral actuator that operates to laterally shift the screed head assembly relative to the base unit in a direction orthogonal to a longitudinal axis of the base unit. A control system is operable to control the lateral actuator to laterally shift the screed head assembly in the direction orthogonal to the longitudinal axis of the base unit to move the screed head assembly toward a wall or structure while the screeding machine moves over uncured concrete in a screeding direction via movement of the base unit along the uncured concrete and alongside the wall or structure.
    Type: Application
    Filed: February 10, 2023
    Publication date: August 17, 2023
    Inventors: Philip D. Halonen, Grant A. Johnson, Mark A. Pietila
  • Patent number: 11673864
    Abstract: The invention relates to pyridone amide compounds of formula I and I? or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: June 13, 2023
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Sara Sabina Hadida Ruah, Corey Anderson, Vijayalaksmi Arumugam, Iuliana Luci Asgian, Brian Richard Bear, Andreas P. Termin, James Philip Johnson
  • Publication number: 20230159502
    Abstract: Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD).
    Type: Application
    Filed: April 2, 2021
    Publication date: May 25, 2023
    Inventors: Simon GIROUX, Michael Philip CLARK, Michael Aaron BRODNEY, Philippe Marcel NUHANT, Emily Elizabeth ALLEN, Robert Francis FIMOGNARI, Jr., Mariam ZAKY, Michael John BOYD, David D. DEININGER, Hu ZHANG, Hongbo DENG, Philip Noel COLLIER, Brad MAXWELL, Nathan D. WAAL, Steven M. RONKIN, Jian WANG, Qing TANG, Gabrielle Simone FLEMING, Peter JONES, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ, Kevin Michael COTTRELL, Upul Keerthi BANDARAGE
  • Publication number: 20230159504
    Abstract: 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD).
    Type: Application
    Filed: April 2, 2021
    Publication date: May 25, 2023
    Inventors: Simon GIROUX, Michael Philip CLARK, Michael Aaron BRODNEY, Peter JONES, Michael Paul DENINNO, Wenxin GU, Qing TANG, Steven David STONE, Timothy J. SENTER, Zachary GALE-DAY, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ, Kevin Michael COTTRELL
  • Publication number: 20230157999
    Abstract: Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
    Type: Application
    Filed: April 2, 2021
    Publication date: May 25, 2023
    Inventors: Michael Philip CLARK, Simon GIROUX, Philip Noel COLLIER, Qing TANG, Nathan D. WAAL, Sarathy KESAVAN, Peter JONES, Michael Aaron BRODNEY, Wenxin GU, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, JR., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ, Kevin Michael COTTRELL
  • Publication number: 20220288057
    Abstract: In certain embodiments, the present disclosure is directed to methods and uses for treating seizure disorders in a human in need thereof, wherein the methods and uses comprise conjointly administering N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide (Compound A) and an antiseizure medication (ASM) to the human in amounts that are therapeutically effective when conjointly administered. The present disclosure is further directed to various improved methods of therapy and administration of Compound A.
    Type: Application
    Filed: February 9, 2022
    Publication date: September 15, 2022
    Inventor: James Philip JOHNSON, JR.
  • Publication number: 20220209540
    Abstract: Described are systems and methods for black-starting an electrical grid, comprising disconnecting an energy farm from the grid at a first location, said first location being located between the electrical grid and the energy storage with the associated converter, providing a synchronous condenser, energizing the AC export cable using said energy storage and the associated converter, energizing at least one part of the energy farm electrical infrastructure via said AC export cable using said energy storage and the associated converter, re-establishing energy supply to said energy farm electrical infrastructure by said electric generators, energizing said synchronous condenser, and reconnecting the energy farm to said electrical grid at said first location.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 30, 2022
    Applicant: ├śrsted Wind Power A/S
    Inventor: Howard Philip JOHNSON
  • Patent number: 11299490
    Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: April 12, 2022
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Jean-Christophe Andrez, Kristen Nicole Burford, Sultan Chowdhury, Charles Jay Cohen, Christoph Martin Dehnhardt, Robert Joseph Devita, James Roy Empfield, Thilo Focken, Michael Edward Grimwood, Syed Abid Hasan, James Philip Johnson, Jr., Alla Yurevna Zenova
  • Publication number: 20220020498
    Abstract: A health risk evaluation system may manage, for a set of users, a corresponding set of digital healthcare profiles, where each digital healthcare profile includes a healthcare decision tree; determine, for a first user, a first subset of the users with a first set of similar digital healthcare profiles based on the corresponding set of healthcare decision trees; determine, based on correlation between a first healthcare decision tree with the first set of healthcare decision trees, a first recommended action; provide information related to the first recommended action; update, for a second user, a second digital healthcare profile and healthcare decision tree; determine the updated second healthcare decision tree deviates from the first set of healthcare decision trees; removing, based on the determined deviation, the second user from the users; determine, based on the updated first set of digital healthcare profiles, a second recommended action; and provide information related to the second recommended actio
    Type: Application
    Filed: June 17, 2021
    Publication date: January 20, 2022
    Inventors: Kristen VALDES, Philips JOHNSON, Yelena BALIN, Imran Iqbal Qureshi, John James Ostlund
  • Patent number: 11203571
    Abstract: The invention relates to compounds of formula I or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: (I). The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: December 21, 2021
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Sara Sabina Hadida-Ruah, Corey Anderson, Andreas P. Termin, Brian Richard Bear, Vijayalaksmi Arumugam, Paul Krenitsky, James Philip Johnson
  • Patent number: 11174268
    Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: November 16, 2021
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Jean-Christophe Andrez, David Earl Bogucki, Kristen Nicole Burford, Sultan Chowdhury, Charles Jay Cohen, Shannon Marie Decker, Christoph Martin Dehnhardt, Robert Joseph Devita, James Roy Empfield, Thilo Focken, Michael Edward Grimwood, Syed Abid Hasan, Qi Jia, James Philip Johnson, Jr., Michael Scott Wilson, Alla Yurevna Zenova
  • Publication number: 20210313071
    Abstract: A health risk evaluation system may manage, for a set of users, a corresponding set of digital healthcare profiles, where each digital healthcare profile includes a healthcare decision tree; determine, for a first user, a first subset of the set of users with a first set of similar digital healthcare profiles based on the corresponding set of healthcare decision trees; determine, for the first user, a second subset of the set of users that are associated with the first user based on a social relationship between the first user and each user in the second subset of users; determine, based on the first set of digital healthcare profiles of the first subset of users and the second set of digital healthcare profiles of the second subset of users, a first recommended action for the first user; and provide, to the first user, information related to the first recommended action.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 7, 2021
    Inventors: Kristen Valdes, Philips Johnson, Yelena Balin, Imran Iqbal Qureshi, John James Ostlund, Jacob Rosales Jason Rosales
  • Publication number: 20210225469
    Abstract: Described herein are systems and methods for receiving healthcare data from a plurality data sources that generate and store data in various data model regimes, many of which are not standardized or are variants of a standard. The stored data may then be used to provide a plurality of customized execution environments and graphical user interfaces (GUIs) to users, based on each user's electronic healthcare records, insurance records, and wearable device data.
    Type: Application
    Filed: April 8, 2021
    Publication date: July 22, 2021
    Inventors: Kristen VALDES, Philips JOHNSON, Yelena BALIN
  • Publication number: 20210213009
    Abstract: In certain embodiments, the present disclosure is directed to methods for treating pain in a subject, such as a human, wherein the methods comprise orally administering a therapeutically effective amount of N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide (Compound A), to the subject in need thereof. The present disclosure is further directed to various improved methods of therapy and administration of Compound A.
    Type: Application
    Filed: December 14, 2020
    Publication date: July 15, 2021
    Applicant: Xenon Pharmaceuticals Inc.
    Inventors: James Philip JOHNSON, JR., Gregory N. BEATCH
  • Publication number: 20210171537
    Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
    Type: Application
    Filed: March 2, 2020
    Publication date: June 10, 2021
    Inventors: Jean-Christophe Andrez, David Earl Bogucki, Kristen Nicole Burford, Sultan Chowdhury, Charles Jay Cohen, Shannon Marie Decker, Christoph Martin Dehnhardt, Robert Joseph Devita, James Roy Empfield, Thilo Focken, Michael Edward Grimwood, Syed Abid Hasan, Qi Jia, James Philip Johnson, JR., Michael Scott Wilson, Alla Yurevna Zenova
  • Patent number: 11004547
    Abstract: Described herein are systems and methods for receiving healthcare data from a plurality data sources that generate and store data in various data model regimes, many of which are not standardized or are variants of a standard. The stored data may then be used to provide a plurality of customized execution environments and graphical user interfaces (GUIs) to users, based on each user's electronic healthcare records, insurance records, and wearable device data.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: May 11, 2021
    Assignee: b.well Connected Health, Inc.
    Inventors: Kristen Valdes, Philips Johnson, Yelena Balin
  • Publication number: 20210047271
    Abstract: The invention relates to pyridone amide compounds of formula I and I? or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain.
    Type: Application
    Filed: June 24, 2020
    Publication date: February 18, 2021
    Inventors: Sara Sabina Hadida Ruah, Corey Anderson, Vijayalaksmi Arumugam, Iuliana Luci Asgian, Brian Richard Bear, Andreas P. Termin, James Philip Johnson
  • Publication number: 20200354354
    Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 12, 2020
    Inventors: Jean-Christophe Andrez, Kristen Nicole Burford, Sultan Chowdhury, Charles Jay Cohen, Christoph Martin Dehnhardt, Robert Joseph Devita, James Roy Empfield, Thilo Focken, Michael Edward Grimwood, Syed Abid Hasan, James Philip Johnson, JR., Alla Yurevna Zenova
  • Patent number: 10738009
    Abstract: The invention relates to pyridone amide compounds of formula I and I? or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: August 11, 2020
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Sara Sabina Hadida Ruah, Corey Anderson, Vijayalaksmi Arumugam, Iuliana Luci Asgian, Brian Richard Bear, Andreas P. Termin, James Philip Johnson
  • Patent number: 10662184
    Abstract: This invention is directed to methods of preparing benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: May 26, 2020
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Jean-Christophe Andrez, Kristen Nicole Burford, Sultan Chowdhury, Charles Jay Cohen, Christoph Martin Dehnhardt, Robert Joseph Devita, James Roy Empfield, Thilo Focken, Michael Edward Grimwood, Syed Abid Hasan, James Philip Johnson, Jr., Alla Yurevna Zenova